Monitoring Methicillin-Resistant Staphylococcus Strains in the Moscow Medical and Surgical Center using Molecular-Biological Methods
https://doi.org/10.31631/2073-3046-2021-20-1-44-50
Abstract
Relevance. Staphylococci are one of the most common pathogens in the etiological structure of nosocomial infections. Methicillinresistant staphylococci are resistant to the main groups of antibiotics and are one of bacteria that pose the greatest threat to human health according to the World Health Organization. The introduction of modern molecular biological methods in the monitoring of methicillin-resistant staphylococci is necessary for the rapid and accurate identification of microorganisms, monitoring the epidemiological situation and studying the need for anti-epidemic measures. Aims. Аnalysis of the results of monitoring methicillinresistant staphylococcus strains using molecular biological methods in a multidisciplinary hospital in Moscow for one year.
Materials and methods. Single-center observational study with a one-year follow-up period (December 2016 to December 2017). The research included a molecular-biological analysis of biological material from 240 patients with signs of infection and washings samples (n=250) from the objects of the hospital environment. The whole genome sequencing was carried out for 24 samples, isolated from patients with different forms of staphylococcal infection and washings from a hospital environment. DNA detection of methicillin-resistant strains was performed using the «AmpliSens®MRSA-screen-titer-FL» reagent kit. Sequencing was performed on an Illumina HiSeq1500 instrument using the IlluminaHiSeq PE RapidClusterKit v2 and IlluminaHiSeqRapid SBS Kit v2.
Results. DNA of methicillin-resistant staphylococci were detected in 6.3% of blood samples from patients with signs of infection and in 42.4% of washings from the objects of the hospital environment. The results of PCR of washing samples showed that DNA of methicillin-resistant coagulase-negative staphylococci were detected much more often than MRSA (p <0.001). DNA of methicillin-resistant staphylococci were detected more often in the intensive care and intensive care units compared with the hematology and surgical departments (p <0.001). The examine samples of Staphylococcus aureus belonged to 6 different sequence types (ST-5, ST-7, ST-8, ST-22, ST-30 and ST-5555) and 8 spatypes (t008, t021, t091, t1062, t12437, t1544, t223, t4573). As a result of monitoring, an isolate with a new allelic profile was found. Today it has been assigned the number ST5555. The predominant type of staphylococcal mec cassette was the type IV SCCmec cassette.
Conclusion. Due to the widespread distribution of methicillin-resistant strains and the identification of epidemiologically significant genetic lines of staphylococci, it is necessary to conduct regular monitoring, take measures to limit the spread of such strains and introduce modern molecular biological methods for quick and accurate identification.
About the Authors
T. S. SkachkovaRussian Federation
Tatyana S. Skachkova – researcher of Department of molecular diagnostics and epidemiology
3a st. Novogireevskaya, Moscow, 111123
M. N. Zamyatin
Russian Federation
Mikhail N. Zamyatin – Dr. Sci. (Med.), Professor of Department of Anesthesiology and Intensive Care Medicine
Moscow
O. A. Orlova
Russian Federation
Oksana A. Orlova – Dr. Sci. (Med.), Head of the Epidemiology Department, Doctor-Epidemiologist, Pirogov National Medical and Surgical Center, Moscow, Russia; researcher, Laboratory of hospital infections, Central Research Institute of Epidemiology
Moscow
N. A. Yumtsunova
Russian Federation
Natalya A. Yumtsunova – epidemiologist assistant
Moscow
N. N. Lashenkova
Russian Federation
Natalya N. Lashenkova – bacteriologist of the bacteriological laboratory
Moscow
V. S. Fomina
Russian Federation
Valeria S. Fomina – Cand. Sci. (Med.), Head of Clinical Laboratory Diagnostics Service
Moscow
V. G. Gusarov
Russian Federation
Vitally G. Gusarov – Cand. Sci. (Med.)
Moscow
Yu. V. Mikhaylova
Russian Federation
Yuliya V. Mikhaylova – Head of laboratory of molecular mechanisms of antibiotic resistance
Moscow
A. A. Shelenkov
Russian Federation
Andrey A. Shelenkov – researcher, Laboratory of Molecular Mechanisms of Antibiotic Resistance
Moscow
E. N. Goloveshkina
Russian Federation
Elena N. Goloveshkina – Cand. Sci. (Biol.), Head of Laboratory for Molecular Diagnostic and Epidemiology of Reproductive Tract Infections
Moscow
V. G. Akimkin
Russian Federation
Vasily G. Akimkin – Dr. Sci. (Med.), Full Member of the Russian Academy of Sciences, Director
Moscow
References
1. Yahav D., Shaked H., Goldberg E., et al. Time trends in Staphylococcus aureus bacteremia, 1988–2010, in a tertiary center with high methicillin resistance rates. Infection. 2017; 45: 51–57. doi:10.1007/s15010-016-0919-6.
2. Olearo F., Albrich W.C., Vernaz N., et al. Staphylococcus aureus and methicillin resistance in Switzerland: regional differences and trends from 2004 to 2014. Swiss Med Wkly. 2016; Sep 15; 146:w14339. eCollection 2016. doi: 10.4414/smw.2016.14339.
3. Jaganath D., Jorakate P., Makprasert S., et al. Staphylococcus aureus Bacteremia Incidence and Methicillin Resistance in Rural Thailand, 2006–2014. The American Journal of Tropical Medicine and Hygiene. 2018; 99 (1): 155–163. doi: https://doi.org/10.4269/ajtmh.17-0631.
4. Khokhlova О.Е., Peryanova O.V., Bobrova O.P., et al. Molecular and genetic features of the methicillin-resistant Staphylococcus aureus (MRSA) – causative agents of purulent diseases at cancer patients (ZHMEI). 2017; 6:15–20 (In Russ). doi:10.36233/0372-9311-2017-6-15-20.
5. Romanov A.V., Dekhnich A.V., Sukhorukova M.V., et al. Antimicrobial resistance of nosocomial Staphylococcus aureus isolates in Russia: results of multicenter epidemiological study «MARATHON» 2013-2014 CMAC. 2017; 1 (In Russ).
6. Dekhnich A. Therapy for nosocomial staphylococcal infections in Russia: it is time to change stereotypes Vrach. 2010; 10: 18–22.
7. Kuzmenkov A.Yu, Trushin I.V, Avramenko, et al. AMRmap: an online platform for monitoring antibiotic resistance CMAC. 2017; 19 (2): 84–90. (In Russ)
8. Zankari E., Hasman H., Cosentino S., et al. Identifi ation of acquired antimicrobial resistance genes. J Antimicrob Chemother. 2012; 67(11):2640–2644. doi: 10.1093/jac/dks261.
9. Carattoli A., Zankari E., Garcia-Fernandez A., et al. Plasmid Finder and pMLST: in silico detection and typing of plasmids. Antimicrob Agents Chemother. 2014; 58(7):3895– 903. doi: 10.1128/AAC.02412-14.
10. Bartels M.D., Petersen A., Worning P., et al. Comparing whole-genome sequencing with Sanger sequencing for spa typing of methicillin-resistant Staphylococcus aureus. J. Clin. Microbiol. 2014; 52(12):4305–8. doi: 10.1128/JCM.01979-14.
11. Romanov А.V., Dekhnich А.V., Edelstein М.V. Molecular epidemiology of Staphylococcus aureus in Russian pediatric hospitals CMAC 2012; 3: 201–208. (In Russ)
12. Afanas’ev M.V., Karakashev S.V., Il’ina E.N., et al. Molecular genetic characterization of methicillin-resistant Staphylococcus aureus isolates recovered from Moscow clinics. Molecular Genetics, Microbiology and Virology . 2010; 2: 20–24 (In Russ).
13. Ishitobi N., Wan T.W., Khokhlova O.E., et al. Fatal case of ST8/SCCmecIVl community‐associated methicillin‐resistant Staphylococcus aureus infection in Japan. New Microbes New Infect. 2018; 26: 30–6. doi: 10.1016/j.nmni.2018.08.004.
14. Morgan M.S. Diagnosis and treatment of Panton–Valentine leukocidin (PVL)-associated staphylococcal pneumonia. International Journal of Antimicrobial Agents. 2007;30(4):289–296. doi: 10.1016/j.ijantimicag.2007.04.019.
15. Labandeira-Rey M., Couzon F., Boisset S. Staphylococcus aureus Panton-Valentine Leukocidin Causes Necrotizing Pneumonia. Science 23. 2007:1130–1133. doi: 10.1126/science.1137165.
Review
For citations:
Skachkova T.S., Zamyatin M.N., Orlova O.A., Yumtsunova N.A., Lashenkova N.N., Fomina V.S., Gusarov V.G., Mikhaylova Yu.V., Shelenkov A.A., Goloveshkina E.N., Akimkin V.G. Monitoring Methicillin-Resistant Staphylococcus Strains in the Moscow Medical and Surgical Center using Molecular-Biological Methods. Epidemiology and Vaccinal Prevention. 2021;20(1):44-50. (In Russ.) https://doi.org/10.31631/2073-3046-2021-20-1-44-50